Aarti Drugs Limited (BOM:524348)

Aarti Drugs Income Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Operating Revenue	25,218	23,870	25,286	27,161	24,886	21,548
Other Revenue	-	-	-	-	0	-
Revenue	25,218	23,870	25,286	27,161	24,886	21,548
Revenue Growth (YoY)	8.22%	-5.60%	-6.90%	9.14%	15.49%	19.31%
Cost of Revenue	16,276	15,614	16,970	19,102	17,022	13,319
Gross Profit	8,942	8,256	8,316	8,058	7,865	8,229
Selling, General & Admin	1,304	1,141	1,047	933.07	840.53	815.37
Other Operating Expenses	4,570	4,244	4,104	4,069	3,640	3,034
Operating Expenses	6,512	5,943	5,666	5,505	4,981	4,348
Operating Income	2,429	2,313	2,650	2,553	2,884	3,881
Interest Expense	-347.23	-358.73	-335.15	-332.93	-207.48	-229.57
Interest & Investment Income	124.09	124.09	24.97	7.02	23.16	36.2
Other Non Operating Income (Expenses)	-89.14	39.51	15.33	14.92	0	-0
EBT Excluding Unusual Items	2,117	2,118	2,355	2,242	2,700	3,688
Asset Writedown	-	-	-	-	-	-30.42
Other Unusual Items	-	-	-	-	-	32.67
Pretax Income	2,117	2,118	2,355	2,242	2,700	3,690
Income Tax Expense	92.54	436.74	639.37	578.25	649.59	886.16
Earnings From Continuing Operations	2,024	1,681	1,716	1,664	2,050	2,804
Minority Interest in Earnings	1.37	0.62	-1.73	-0.48	0.43	0.15
Net Income	2,026	1,682	1,714	1,663	2,050	2,804
Net Income to Common	2,026	1,682	1,714	1,663	2,050	2,804
Net Income Growth	32.74%	-1.90%	3.07%	-18.89%	-26.88%	98.31%
Shares Outstanding (Basic)	91	91	92	93	93	93
Shares Outstanding (Diluted)	91	91	92	93	93	93
Shares Change (YoY)	-0.18%	-0.72%	-0.72%	-	-0.64%	-
EPS (Basic)	22.20	18.42	18.65	17.96	22.14	30.09
EPS (Diluted)	22.18	18.42	18.65	17.96	22.14	30.09
EPS Growth	32.91%	-1.19%	3.82%	-18.89%	-26.41%	98.31%
Free Cash Flow	-	674.22	1,326	-314.97	-815.61	667.19
Free Cash Flow Per Share	-	7.39	14.42	-3.40	-8.81	7.16
Dividend Per Share	2.000	1.000	1.000	1.000	1.000	2.500
Dividend Growth	100.00%	-	-	-	-60.00%	400.00%
Gross Margin	35.46%	34.59%	32.89%	29.67%	31.60%	38.19%
Operating Margin	9.63%	9.69%	10.48%	9.40%	11.59%	18.01%
Profit Margin	8.03%	7.04%	6.78%	6.12%	8.24%	13.01%
Free Cash Flow Margin	-	2.83%	5.24%	-1.16%	-3.28%	3.10%
EBITDA	2,990	2,843	3,140	3,028	3,353	4,335
EBITDA Margin	11.86%	11.91%	12.42%	11.15%	13.47%	20.12%
D&A For EBITDA	560.94	530.44	489.77	475.43	469.4	453.3
EBIT	2,429	2,313	2,650	2,553	2,884	3,881
EBIT Margin	9.63%	9.69%	10.48%	9.40%	11.59%	18.01%
Effective Tax Rate	4.37%	20.62%	27.15%	25.79%	24.06%	24.01%
Revenue as Reported	25,253	24,034	25,326	27,182	25,000	21,593
Advertising Expenses	-	17.91	23.3	11.67	13.5	9.81

Source: S&P Global Market Intelligence. Standard template. Financial Sources.